twice a day

2 trials

Sponsors

Beijing Chaoyang Hospital, Capital Medical University, Kashan University of Medical Sciences

Conditions

Diabets type 2. Non-insulin-dependent diabetes mellitusNovel Coronavirus Pneumonia (COVID-19)

Phase 2

A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)

RecruitingChiCTR2000029996

Beijing Chaoyang Hospital, Capital Medical UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-20Updated: 2020-02-25

Phase 3

Effect of Morus Alba leaves’s extract supplement on type 2 diabetes

Active, not recruitingIRCT2016081312438N21

Kashan University of Medical SciencesDiabets type 2. Non-insulin-dependent diabetes mellitus

Start: 2016-11-21Target: 60Updated: 2022-05-02

Related Papers

Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: A double-blind clinical trial.

2022-03-2412 citations